๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

HRT in women with type 2 diabetes

โœ Scribed by JAMIESON, ANDREW


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
47 KB
Volume
17
Category
Article
ISSN
1357-8170

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Why I would encourage my wife to take HR
โœ Gill, Geoff ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 56 KB ๐Ÿ‘ 1 views

Post-menopausal type 2 diabetic patients are at enormous risk of increased mortality and morbidity from coronary artery disease (CAD). Attempts to modify contributory risk factors are likely to be only partially successful, and any other beneยฎcial strategy should be vigorously adopted. Such a potent

Glutathione in overweight patients with
โœ Jan Aaseth; Grethe Stรธa-Birketvedt ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 114 KB ๐Ÿ‘ 1 views

Increased lipid peroxidation due to an altered intracellular ratio between free radicals and antioxidant systems has been associated with development of diabetic complications. This report explores the biochemical reliability of this hypothesis by measuring glutathione (GSH) in overweight patients w

Toxicity of hyperglycaemia in Type 2 dia
โœ Hannele Yki-Jรคrvinen ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 141 KB ๐Ÿ‘ 1 views
Fibrinolytic measurements in Type 2 diab
โœ Mansfield, M.W.; Catto, A.J.; Carter, A.M.; Grant, P.J. ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 92 KB

The aim of this study was to investigate disturbances in fibrinolytic components in Type 2 diabetes patients with acute ischaemic stroke. Levels of plasminogen activator inhibitor-1 (PAI-1) activity and tissue PA (t-PA) antigen were measured in Type 2 diabetes subjects with (n=40) and without (n=80)

Atherogenic lipoprotein phenotype in Typ
โœ Michael D. Feher; Muriel Caslake; Julie Foxton; Alison Cox; Christopher J. Packa ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 77 KB

## Background: To assess the short-term effects of a micronised formulation of fenofibrate on lipids, lipoproteins and their composition, reflecting an atherogenic lipoprotein phenotype (alp), in patients with stable type 2 diabetes. ## Methods: Thirty-two (18 male, 14 female) patients with type